By Admin at 23 Oct 2015

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and although survival rates vary from two to 20 years after diagnosis, it is considered incurable with conventional therapies. While stem cell transplants may provide a cure, not all patients are eligible for the procedure, which is why a new experimental therapy, called CTL019, is raising hope for many.